Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 2/3 1

Status

Unknown 3Completed 3

Sponsor Class

NIH 4OTHER 2

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Multiple Myeloma 121Neoplasms, Plasma Cell 36Neoplasms 14Carcinoma, Hepatocellular 13Recurrence 12Brain Neoplasms 12Prostatic Neoplasms 11Melanoma 11Central Nervous System Neoplasms 11Glioblastoma 10Leukemia 9Carcinoma, Non-Small-Cell Lung 9Leukemia, Lymphocytic, Chronic, B-Cell 8Gliosarcoma 8Waldenstrom Macroglobulinemia 7Sarcoma 7Lung Neoplasms 7Glioma 7Colorectal Neoplasms 7Carcinoma, Renal Cell 7Liver Neoplasms 6Myeloproliferative Disorders 5Myelodysplastic Syndromes 5Lymphoma, Mantle-Cell 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma 5Kidney Neoplasms 5Immunoglobulin Light-chain Amyloidosis 5Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, Follicular 4

Interventions

Sorafenib 68Bevacizumab 44Oxaliplatin 25Doxorubicin 22Gemcitabine 21Fluorouracil 21Radiosurgery 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17lenvatinib 17Cisplatin 17Capecitabine 17atezolizumab 14Leucovorin 14Hepatectomy 14Radiotherapy 12tremelimumab 10Irinotecan 10Drug Therapy 10Cyclophosphamide 10Carboplatin 10Blood Specimen Collection 10Ipilimumab 9regorafenib 8Liver Transplantation 8Everolimus 8Cryosurgery 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Liver Neoplasms × Thalidomide × Clear all
NCT07321613 2026-01-07

Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients

Shanghai Zhongshan Hospital

Completed
545 enrolled
Gastrointestinal

Liver Neoplasms

NCT00276705 2013-09-17

Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
47 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00058487 2013-07-18

Epirubicin and Thalidomide in Treating Patients With Liver Cancer

National Cancer Institute (NCI)

Phase 2 Completed
12 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00006006 2013-02-11

Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed

National Cancer Institute (NCI)

Phase 2 Completed
38 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00728078 2009-02-09

LDT-RFA

Sun Yat-sen University

Phase 2/3 Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00006198 2005-06-24

Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer

National Center for Research Resources (NCRR)

Phase 2 Unknown
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡